Related Experiment Video
Updated: Jun 7, 2026

Technical Approach for Infrared Tracking for Soft Tissue Navigation with a Holographic Head-Mounted Display and Preclinical Validation
Published on: September 2, 2025
Markerless augmented reality registration for surgical guidance: a multi-anatomy clinical accuracy study
Yue Yang1,2, Fabian Necker1, Christoph Leuze1
1School of Medicine, Stanford University, Stanford, CA, 94305, USA.
Purpose:
In this paper, we develop and clinically evaluate a depth-only, markerless augmented reality (AR) registration pipeline on a head-mounted display, and assess accuracy across small, or low-curvature anatomies in real-life operative settings.
Methods:
In HoloLens 2, we align Articulated HAnd Tracking (AHAT) depth to Computed Tomography (CT)-derived skin meshes via (i) depth-bias correction, (ii) brief human-in-the-loop initialization, (iii) global and local registration. We validated the surface-tracing error metric by comparing "skin-to-bone" relative distances to CT ground truth on leg and foot models, using an AR tracked tool. We then performed seven intraoperative target trials (feet 2, ear 3, leg 2) during the initial stage of fibula free-flap harvest and mandibular reconstruction surgery, and collected 500+ data per trial.
Results:
Preclinical validation showed tight agreement between AR-traced and CT distances (leg: median 0.78 mm, RMSE 0.97 mm; feet: 0.80 mm, 1.20 mm). Clinically, per-point error had a median 3.9 mm. Median errors by anatomy were 3.2 mm (feet), 4.3 mm (ear), and 5.3 mm (lower leg), with 5 mm coverage 92-95%, 84-90%, and 72-86%, respectively. Feet vs. lower leg differed significantly ( median 1.1 mm; ) CONCLUSIONS: A depth-only, markerless AR pipeline on HMDs achieved 3-4 mm median error across feet, ear, and lower leg in live surgical settings without fiducials, approaching typical clinical error thresholds for moderate-risk tasks. Human-guided initialization plus global-to-local registration enabled accurate alignment on small or low-curvature targets , improving the clinical readiness of markerless AR guidance.

